• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    Neurocrine Biosciences Inc. (NBIX)

    -NasdaqGS
    46.67 Up 0.41(0.89%) Aug 28, 4:00PM EDT
    Add to Portfolio
    Prev Close:46.26
    Open:46.21
    Bid:N/A
    Ask:48.55 x 100
    1y Target Est:64.00
    Beta:-1.91249
    Earnings Date:Nov 2 - Nov 6 (Est.)
    Day's Range:45.78 - 47.74
    52wk Range:15.10 - 56.18
    Volume:752,795
    Avg Vol (3m):853,105
    Market Cap:4.01B
    P/E (ttm):N/A
    EPS (ttm):-0.76
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NBIX

    Comparison

    Symbol% ChgMkt Cap
    NBIXUp 0.89%4.01B
    ABTUp 0.83%68.59B
    PFEDown 1.80%201.43B
    LLYDown 0.66%88.10B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):200.95
    Ex-Dividend Date:29-Dec-95

    Analysts

    Annual EPS Est (Dec-15) :-0.83
    Quarterly EPS Est (Sep-15) :-0.25
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):6.07

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback